BenchSci logo — We empower scientists with the world’s most advanced biomedi...

BenchSci

We empower scientists with the world’s most advanced biomedical artificial intelligence.

Founded 2015 Canada Toronto, Canada 242 employees Series D+ Total: $203.11M AI, Biotechnology +3

General Information

Company Name BenchSci
Founded Year 2015
Location Canada Toronto, Canada
Employees 242
Industries AI, Biotechnology, Life Sciences +2
Funding Stage Series D+
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Tiered Pricing, Service Fee

BounceWatch is an independent company data service, not affiliated with BenchSci. To contact BenchSci, visit benchsci.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BenchSci compare?

A PDF of BenchSci and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BenchSci soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BenchSci

BenchSci, founded in 2015, is a Canada-based startup at the intersection of AI, Biotechnology, and Life Sciences. The company's mission is articulated in its slogan: "We empower scientists with the world's most advanced biomedical artificial intelligence." Its platform is utilized by 16 of the top 20 pharmaceutical companies, evidencing significant market penetration and trust.

The company has garnered substantial investor confidence, as indicated by its latest $95.00M Series D round on 01 May 2023, supported by notable investors like Golden Ventures, F-Prime Capital, iNovia Capital, Generation Investment Management, and TCV. This funding underscores its scalability potential and innovation leadership within a competitive industry.

With recognition from accolades such as Deloitte Tech Fast 50, CIX Top 10 Growth, and Great Place to Work, BenchSci exemplifies both promising growth metrics and a strong cultural ethos, making it an attractive prospect for forward-thinking investors.

Business keywords: Biomedical Artificial Intelligence, Drug Discovery, Pharmaceutical Companies, Research Centers, Scientific Experimentation, Remote-first Company, Antibody Research, Reagent Work, Online Scientific Platform, AI for Healthcare, Life Sciences

Services & Products

agentic workbench for disease biology
scientific reasoning unification
data and model orchestration
experimental design assistance
target identification and validation
lead optimization

Target Customers

biopharmaceutical companies academic researchers scientists involved in drug discovery R&D departments in life sciences

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $95.00M 5
Golden Ventures, F-Prime Capital +3
01 May 2023
Series C $63.00M 4
Golden Ventures, iNovia Capital +2
01 Jan 2022
Series B $10.00M 1
F-Prime Capital
01 Feb 2021
Series B $22.00M 4
Real Ventures, F-Prime Capital +2
01 Feb 2020
Series A Extension $5.10M 1
Gradient Ventures
01 Jun 2019
Series A $8.00M 5
Real Ventures, iNovia Capital +3
01 May 2018
Seed Undisclosed 1
Radical Investments
01 Jun 2017
Seed Undisclosed 3
Real Ventures, Afore Capital +1
01 Oct 2016
Seed Undisclosed 2
Two Small Fish Ventures, Ontario Centre of Innovation
01 May 2016
Grant Undisclosed -
01 Oct 2015

View All 11 Funding Rounds

BenchSci Alternatives & Competitors

View All Alternatives
BenchSci vs
Ascent Bio
Ascent Bio United States

Building the future of molecule intelligence

2 employees
AI, Health Care
BenchSci vs

AI-powered scientific intelligence platform for early-stage research and innovation scouting

Seed
15 employees
Analytics, Big Data
BenchSci vs
Causaly
Causaly United Kingdom

Unlock R&D productivity with the most complete AI platform for life sciences.

Series B
119 employees
Biotechnology, Pharmaceutical

FAQ About BenchSci

We empower scientists with the world’s most advanced biomedical artificial intelligence.
BenchSci was founded in 2015.
BenchSci is headquartered in Toronto, Canada.
BenchSci operates in AI, Biotechnology, Life Sciences, Pharmaceutical and Machine Learning. Its work centres on Biomedical Artificial Intelligence, Drug Discovery, Pharmaceutical Companies and Research Centers. Its customers include biopharmaceutical companies, academic researchers and scientists involved in drug discovery.
BenchSci has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Tiered Pricing and Service Fee.
BenchSci has approximately 242 employees.
BenchSci has completed 11 funding rounds, raising a total of $203.11M. The latest funding stage is Series D+.
BenchSci offers: agentic workbench for disease biology, scientific reasoning unification, data and model orchestration, experimental design assistance, target identification and validation, lead optimization.
Top alternatives and competitors to BenchSci include Ascent Bio, AcademicLabs, Causaly, iktos, BenevolentAI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BenchSci and Ascent Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BenchSci, https://bouncewatch.com/company/benchsci, updated 1 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes